Helius Medical (HSDT) Technologies announced an additional authorized claim for payment for the PoNS Device from CignaHealth. CignaHealth becomes the fifth major payer to authorize claims for payment for the PoNS Device following the recent authorization by Anthem MultiPlan. “With approvals now secured from five major commercial healthcare payers, we are making significant progress increasing MS patient access to the PoNS device,” said Dane Andreeff, Helius President and Chief Executive Officer. “Importantly, these out-of-network total lump sum reimbursement payments at over $19,000, reinforce the value of PoNS while strengthening and supporting our ongoing efforts to achieve broader reimbursement from CMS and coverage across the healthcare landscape.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSDT:
- Helius Medical announces presentation of PoNSTEP study results
- Why Is Helius Medical Tech Stock (HSDT) Up 100% Today?
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
- Helius Medical announces authorized claim for payment for PoNS device
- Helius Medical Technologies Achieves Nasdaq Bid Price Compliance